<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72068">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01751542</url>
  </required_header>
  <id_info>
    <org_study_id>8888-B</org_study_id>
    <nct_id>NCT01751542</nct_id>
  </id_info>
  <brief_title>Mindfulness and Acceptance Group Therapy for Substance Use</brief_title>
  <official_title>Mindfulness and Acceptance Group Therapy for Substance Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Tennessee Knoxville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Tennessee Knoxville</source>
  <oversight_info>
    <authority>United States: University of Tennessee-Knoxville IRB</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical trial comparing standard residential substance abuse treatment to
      standard residential treatment plus Mindfulness and Acceptance Group Therapy for substance
      use.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Substance use after discharge from treatment</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Substance Use Disorder</condition>
  <arm_group>
    <arm_group_label>Mindfulness + residential treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mindfulness and Acceptance Group Therapy + residential treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Residential Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Residential treatment alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness + Residential Treatment</intervention_name>
    <arm_group_label>Mindfulness + residential treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Residential treatment alone</intervention_name>
    <arm_group_label>Residential Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  participating in inpatient substance use treatment at treatment facility

        Exclusion Criteria:

          -  psychosis and mental impairment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Tenneessee &amp; Cornerstone of Recovery</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37996</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Stuart, PhD</last_name>
      <phone>865-974-3358</phone>
    </contact>
    <investigator>
      <last_name>Gregory L Stuart, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ryan Shorey, MA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 13, 2012</lastchanged_date>
  <firstreceived_date>December 13, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
